Member Info for Size82

Agreed Doc D. I've been adding recently. Feels like the sp is bottoming out. GLA

I'll name one thing Mani. He raised a sh*t load of cash, didn't manage trial risk correctly and blew it. Lucky boy to have kept his job. Obviously did a good job at convincing our largest shareholder he was the right man to turn the situation around.

Benefit of the doubt given here, but he needs to start delivering and to the timetable he set. The clock is ticking.

Hopefully Tatyhead61!

I'm still here Trinityman it's just I don't have much to add right now. All I will say is I have faith given the sprinter deepdive analysis, the strategy is probably correct, the company have the capital to fund pH 2's (trust their word on this) and we have a shareholder to ward off hostile takeovers (and hopefully) look out for our interests. The communication has been poor (like embarrassing really) and RM should show his face more, but hopefully one day from now when least expected we will get an RNS stating we're on track / starting the phase 2's. Chin up everyone.

GLA

I think that's a fair assessment Doc83

GLA

Oh Mani.... I can't believe you didn't get that one!

Mani, you are full of hot air ;-)

Ouch, you've changed your tune spacman. I'd say this is the time to not get too wound up by the lack of comms and stay patient. Just accept everything takes twice as long as we'd like. If anything the sp looks like a buy right now, although my gut feeling tells me this will go lower in the near term. GLA

Mani, pinch of salt comment obviously, but you know what I mean.... :-)

* even if we are talking pence not pounds. A few grand right now goes a long way right now...

I think a year ago there was still genuine anticipation this could be picked up by a platform trial on the back on the Sprinter deepdive. From memory this the annual report put a dampener on that. Hindsight is a wonderful thing...

Looking to the future, I do see the continual degradation of the share price until news hits. Its pretty obvious RM isn't incentivied to keep the tires pumped up on the sp. Lack of communication and lack of a shave says it all. Things can turn around pretty quickly though. Start of phase 2 trials and the results (which should take months, not years) could create a significant re-rate. GLA

They'll be good money to be made at these low (and I anticipate lower to come prices) through to phase 2 results.

Workbench1.3 - doubt it. I can see this halving in price as we drift along waiting for news, which could easily be another 2, 3, 4 months.

I doubt TFG would sell for 100 gbx. Probably not much more than their breakeven. If the diagnostics technology is inplace and p2 results are good any DCF valuation would justify a high chance of ph3 success in an exit valuation. Thus, an NPV at that point would be much higher. All gloves are off on the real worth of a successful phase 3. Maybe TFG will stick around and such up some dilution via a BP JV to deliver a ph3 result. Who knows. Anyway, one step at a time as we need those diagnostics and ph2 to start first!

GLA

Spacman, one thing for sure is the diagnostics on who will have a strong respond in advance is key. If they can do this in a highly efficient manner then the size of the market is likely to be significant.

I believe not knowing this already is why SNG001 has neither been picked up by a BP or a platform trial despite the strong Sprinter deepdive results.

No idea on the timings for a JV that you suggest.

BTW, this is very creative - "Keep going TFG (Tommy-Fruits-Gunto lol)". Lol

Gla

Lol, very good RM

Fairly pessimistic view there Manifesto. I don't think our largest shareholder would allow a raise at these sp levels unless absolutely desperate and I don't think we are at that stage. Interesting point on the use by date of the existing SNG001 stock. Not something I could answer, but a good question for investor relations (if one actually exists now).

Why would there be a placing in H1 2024? The company has ample cash and assuming the sp won't materially rise until after the ph2 results it would be highly dilutive. It would therefore be negative for our largest shareholder. Just can't see it happening.

Spaceman, out of interest what do you think Synairgen's patents are worth?

Manifesto, RM's statement you posted below was also made back in Sept 2022.